EYPT: Strong secondary outcomes and safety drive optimism ahead of pivotal LUCIA trial and DME expansion
Recent phase III data showed strong secondary outcomes and safety, despite missing the primary endpoint due to unusual control arm results. The upcoming LUCIA trial, with improved analysis, is expected to be pivotal for regulatory approval and commercial success, while expansion into DME and manufa…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.